scispace - formally typeset
C

Charles H. Hennekens

Researcher at Harvard University

Publications -  439
Citations -  120693

Charles H. Hennekens is an academic researcher from Harvard University. The author has contributed to research in topics: Risk factor & Relative risk. The author has an hindex of 150, co-authored 424 publications receiving 117806 citations. Previous affiliations of Charles H. Hennekens include University of Auckland & Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

Dietary intake of α-linolenic acid and risk of fatal ischemic heart disease among women

TL;DR: This study supports the hypothesis that a higher intake of α-linolenic acid is protective against fatal ischemic heart disease and higher consumption of foods such as oil-based salad dressing that provide polyunsaturated fats, including α-linsolenic Acid, may reduce the risk of fatal IHD.
Journal ArticleDOI

A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction

TL;DR: The data do not support the use of Lp(a) level as a screening tool to define cardiovascular risk among this population of predominantly middle-aged white men, and no evidence of association between Lp-a level and risk of future MI is found.
Journal ArticleDOI

Prospective study of exogenous hormones and risk of pulmonary embolism in women.

TL;DR: In this paper, the relationship between postmenopausal use of oral contraceptives and venous thrombosis and pulmonary embolisms was investigated using questionnaires sent every 2 years (1976-92) to 112,593 women aged 30-55 in 1976.
Journal ArticleDOI

Prospective Study of Shift Work and Risk of Coronary Heart Disease in Women

TL;DR: Data from this prospective cohort of US female nurses are compatible with the possibility that 6 or more years of shift work may increase the risk of CHD in women.
Journal ArticleDOI

Dietary Fat and the Risk of Breast Cancer

TL;DR: It is suggested that a moderate reduction in fat intake by adult women is unlikely to result in a substantial reduction in the incidence of breast cancer, based on a limited period of follow-up.